Premium
Assessment of human antihuman antibodies to eculizumab after long‐term treatment in patients with paroxysmal nocturnal hemoglobinuria
Author(s) -
Hillmen Peter,
Muus Petra,
Szer Jeffrey,
Hill Anita,
Höchsmann Britta,
Kulasekararaj Austin,
Risitano Antonio M.,
Van Den Neste Eric,
Liljeholm Maria,
Ebrahim Kurt S.,
Bedrosian Camille L.,
Gao Xiang,
Ames Donna,
Socié Gérard
Publication year - 2016
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24280
Subject(s) - eculizumab , paroxysmal nocturnal hemoglobinuria , medicine , hemoglobinuria , clinical trial , immunogenicity , antibody , pediatrics , immunology , complement system , anemia
CARMEN BALDAZZI,* SIMONA LUATTI, STEFANIA PAOLINI, CRISTINA PAPAYANNIDIS, GIULIA MARZOCCHI, GAIA AMELI, GIOVANNI MARTINELLI MICHELE CAVO AND NICOLETTA TESTONI Institute of Hematology and Medical Oncology, “Lorenzo E Ariosto Ser agnoli”, Sant’Orsola-Malpighi Hospital-University of Bologna, Bologna, Italy Additional Supporting Information may be found in the online version of this article. *Correspondence to: Carmen Baldazzi, PhD; Institute of Hematology and Medical Oncology “Lorenzo e Ariosto Seragnoli”, Sant’Orsola-Malpighi Hospital-University, Via Massarenti 9, 40138 Bologna, Italy. E-mail: carmen.baldazzi@gmail.com Received for publication: 7 December 2015; Accepted: 11 December 2015 Published online: 15 December 2015 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/ajh.24276